Your session is about to expire
← Back to Search
Radiation Therapy
Group 1: 10 Gy Low-KV IORT for Pancreatic Cancer (IORT Trial)
Phase 1
Waitlist Available
Research Sponsored by Loyola University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 52 weeks
Awards & highlights
IORT Trial Summary
This trial is testing whether adding radiation therapy to surgery helps people with pancreatic cancer live longer.
Eligible Conditions
- Pancreatic Cancer
IORT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 52 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~52 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Maximum Tolerated Dose
Secondary outcome measures
Diet Surveys
IORT Trial Design
3Treatment groups
Experimental Treatment
Group I: Group 3: 20 GY Low-KV IORTExperimental Treatment1 Intervention
20 GY Low Kilovoltage Intraoperative Radiation: intraoperative low-kV IORT will be delivered as a single dose of 20 Gy at 2 millimeter depth. Patients will be accrued to this group until the DLT is reached and MTD is realized.
Group II: Group 2: 15 Gy Low-KV IORTExperimental Treatment1 Intervention
15 Gy Low Kilovoltage Intraoperative Radiation: intraoperative low-kV IORT will be delivered as a single dose of 15 Gy at 2 millimeter depth. Doses will be escalated in increments of 5 Gy until completion of 20 Gy dose level or the DLT is reached and MTD is realized.
Group III: Group 1: 10 Gy Low-KV IORTExperimental Treatment1 Intervention
10 Gy Low Kilovoltage Intraoperative Radiation: intraoperative low-kV IORT will be delivered as a single dose of 10 Gy at 2 millimeter depth. Doses will be escalated in increments of 5 Gy until completion of 20 Gy dose level or the DLT is reached and MTD is realized.
Find a Location
Who is running the clinical trial?
Loyola UniversityLead Sponsor
156 Previous Clinical Trials
30,922 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger